Concepedia

Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity

Hirofumi Akita, Hiroaki Nagano, Yutaka Takeda, Hidetoshi Eguchi, Hiroshi Wada, Shogo Kobayashi, Shigeru Marubashi, Masahiro Tanemura, Hidenori Takahashi, Hiroaki Ohigashi,

Oncogene · 2011 · 43 citations · 44 references

DOI

Concepts

References

44

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

Identification of Pancreatic Cancer Stem Cells

Chenwei Li, David G. Heidt, Piero Dalerba et al. · Cancer Research · 2007 · 3.4K citations · Full text

, , +17

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

Helmut Oettle, Stefan Post, P. Neuhaus et al. · JAMA · 2007 · 2.4K citations

, , +13

Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators

Taylor A. Sohn, Charles J. Yeo, John L. Cameron et al. · Journal of Gastrointestinal Surgery · 2000 · 1.5K citations

, , +12

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database11No competing interests declared.

Stephen Sener, Amy M. Fremgen, Herman R. Menck et al. · Journal of the American College of Surgeons · 1999 · 793 citations

, , +11